SAN DIEGO, Dec. 3, 2025 /PRNewswire/ -- Sanguine Biosciences, a leading provider of high-quality human biospecimens and real-world clinical data, today announced the expansion of its clinical sample ...
HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to ...
Source BioScience UK has acquired clinical healthcare testing service provider Cambridge Clinical Laboratories (CCL), enhancing its clinical diagnostics portfolio. The acquisition enables Source ...
Further data will highlight the clinical pharmacokinetic/pharmacodynamic relationship of DZD2269, a potent and selective A2aR antagonist designed to overcome high ...
Following FDA approval last year, Illumina's TSO Comprehensive test gains broad payer reimbursement, expanding access to comprehensive genomic profiling to match patients with targeted therapies ...
Positive preliminary analysis of 15 mg cohort in the PRAX-628 study in epilepsy patients with Photo-Paroxysmal Response (PPR) exceeds expectations; topline results expected in 1Q 2024 after completion ...
NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Equum Medical, one of the nation’s leading providers of acute telehealth-enabled clinical workforce solutions, today announced it has acquired the ...
For my initial rating of Amneal Pharmaceuticals, I am calling it a buy. I was impressed by its large, diversified portfolio of therapies across clinical segments, and active pipeline of future ...
Praxis Precision Medicines (PRAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Douglas Tsao from H.C. Wainwright remains neutral on the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback